These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19557465)
1. [Urine-based markers of angiogenesis in bladder cancer]. Becker M; Tilki D; Szarvas T; Rübben H; Ergün S Urologe A; 2009 Jun; 48(6):609-14. PubMed ID: 19557465 [TBL] [Abstract][Full Text] [Related]
2. [Urine-based diagnostics: an update on the Kiel Tumor Bank]. Hautmann S; Lokeshwar VB; Juenemann KP Urologe A; 2009 Jun; 48(6):619-24. PubMed ID: 19557467 [TBL] [Abstract][Full Text] [Related]
3. [Use of marker systems in the treatment of bladder cancer]. Burger M; Vom Dorp F Urologe A; 2011 Mar; 50(3):303-8. PubMed ID: 21340598 [TBL] [Abstract][Full Text] [Related]
4. [Urine-based oncological diagnostic for bladder carcinoma: what is new?]. Rübben H Urologe A; 2009 Jun; 48(6):597. PubMed ID: 19557463 [No Abstract] [Full Text] [Related]
5. [Urine markers with special regard to fluorescent in situ hybridization (FISH)]. Lindemann-Docter K; Gaisa NT; Smeets D; Knüchel-Clarke R Urologe A; 2011 Mar; 50(3):297-302. PubMed ID: 21253689 [TBL] [Abstract][Full Text] [Related]
6. Current Use and Promise of Urinary Markers for Urothelial Cancer. Tabayoyong W; Kamat AM Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534 [TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis in bladder: prognosis indicator and therapeutic target]. Chabannes E; Bernardini S; Wallerand H; Bittard H Prog Urol; 2001 Jun; 11(3):417-27. PubMed ID: 11512452 [TBL] [Abstract][Full Text] [Related]
15. New diagnostic and prognostic tools in bladder cancer. Tiguert R; Fradet Y Curr Opin Urol; 2002 May; 12(3):239-43. PubMed ID: 11953681 [TBL] [Abstract][Full Text] [Related]
16. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Ng K; Stenzl A; Sharma A; Vasdev N Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875 [TBL] [Abstract][Full Text] [Related]
17. Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers. Zuiverloon TCM; de Jong FC; Theodorescu D Oncology (Williston Park); 2017 Dec; 31(12):855-62. PubMed ID: 29297169 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic, prognostic and surveillance urinary markers in nonmuscle invasive bladder cancer: any role in clinical practice? Soria F; D'Andrea D; Pohar K; Shariat SF; Lotan Y Curr Opin Urol; 2018 Nov; 28(6):577-583. PubMed ID: 30157039 [TBL] [Abstract][Full Text] [Related]
19. [The role of tumor markers in urologic consultation for screening, diagnosis, and follow-up of bladder cancer]. Lorenzo Gómez MF Actas Urol Esp; 2003 Feb; 27(2):110-6. PubMed ID: 12731325 [TBL] [Abstract][Full Text] [Related]
20. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot. Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]